免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

OnSite-IV

K号: K161800 · 2016-12-06

申请人Pharmc, LLC
决定日期2016-12-06
产品代码LHI
咨询委员会医疗设备监管文本翻译如下: HO 请注意,由于您没有提供具体的医疗设备监管文本内容,以上仅为示例。请提供具体的文本内容以便进行准确的翻译。
决定实质等同

器械摘要

OnSite-IV is the device name listed in this FDA 510(k) record. The listed applicant is Pharmc, LLC. It received FDA 510(k) clearance on 2016-12-06 under 510(k) number K161800. The device is classified under product code LHI. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the OnSite-IV?

OnSite-IV is a medical device that received FDA 510(k) clearance on 2016-12-06. The listed applicant is Pharmc, LLC. The 510(k) number is K161800.

When did OnSite-IV receive FDA 510(k) clearance?

OnSite-IV received FDA 510(k) clearance on 2016-12-06, under 510(k) number K161800.

Who is the listed applicant for OnSite-IV?

The FDA 510(k) record lists Pharmc, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OnSite-IV?

The FDA product code for OnSite-IV is LHI.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:LHI)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑